Literature DB >> 9027303

A Unified Theory Based on SO(5) Symmetry of Superconductivity and Antiferromagnetism

.   

Abstract

The complex phase diagram of high-critical temperature (Tc) superconductors can be deduced from an SO(5) symmetry principle that unifies antiferromagnetism and d-wave superconductivity. The approximate SO(5) symmetry has been derived from the microscopic Hamiltonian, and it becomes exact under renormalization group flow toward a bicritical point. This symmetry enables the construction of a SO(5) quantum nonlinear final sigma model that describes the phase diagram and the effective low-energy dynamics of the system. This model naturally explains the basic phenomenology of the high-Tc superconductors from the insulating to the underdoped and the optimally doped region.

Year:  1997        PMID: 9027303     DOI: 10.1126/science.275.5303.1089

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Thermodynamics of the interplay between magnetism and high-temperature superconductivity.

Authors:  S A Kivelson; G Aeppli; V J Emery
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

2.  Ground-state phase diagram of the t-t'-J model.

Authors:  Shengtao Jiang; Douglas J Scalapino; Steven R White
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-02       Impact factor: 11.205

3.  The analytic structure of the fixed charge expansion.

Authors:  Oleg Antipin; Jahmall Bersini; Francesco Sannino; Matías Torres
Journal:  J High Energy Phys       Date:  2022-06-08       Impact factor: 6.379

4.  Local particle-hole pair excitations by SU(2) symmetry fluctuations.

Authors:  X Montiel; T Kloss; C Pépin
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

5.  Charged skyrmions and topological origin of superconductivity in magic-angle graphene.

Authors:  Eslam Khalaf; Shubhayu Chatterjee; Nick Bultinck; Michael P Zaletel; Ashvin Vishwanath
Journal:  Sci Adv       Date:  2021-05-05       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.